3.67 Thoughts on PhD Programs and Idecabtagene Vicleucel with Dr. David Russler-Germain

OncologyMedicineHealth Policy
Written By Kerrington .

Today we bring back popular guest Dr. David Russler-Germain, a Hematology/Oncology Fellow at the Washington University School of Medicine in St. Louis, to discuss his thoughts on PhD programs (in response to a listener question) as well as his take on Idecabtagene vicleucel for multiple myeloma.

Kerrington .
Previous

3.68 A Career in Academic Medicine & Challenges of 2021 with Former Harvard Dean, Dr. Jeffrey Flier
Next

3.66 COVID-19 Policies and Progressing Past Disagreement with Dr. Martin Kulldorff